OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
6
Results
Show all
Save search
Copy query
Show results for
Unknown
(6)
Publication Date
Release Date
2021
(3)
2025
(1)
2023
(1)
2022
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells.
Not available
S-EPMC10189188
|
biostudies-literature
Cite
RBD-specific polyclonal F(ab´)
2
fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial.
Not available
S-EPMC8037439
|
biostudies-literature
Cite
Co-creation of the logic model for a health-promoting school program in vulnerable areas in a Brazilian capital: ProMOVE Escolas + Saudaveis.
Not available
S-EPMC12706980
|
biostudies-literature
Cite
Characteristics, management, and outcomes of patients with left-sided infective endocarditis complicated by heart failure: a substudy of the ESC-EORP EURO-ENDO (European infective endocarditis) registry.
Not available
S-EPMC9543970
|
biostudies-literature
Cite
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
Not available
S-EPMC8362594
|
biostudies-literature
Cite
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
Not available
S-EPMC8362592
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets